Use of Casirivimab and Imdevimab for the Treatment of COVID-19

The authors present three cases of unvaccinated coronavirus disease 2019 (COVID-19) patients who exhibited symptoms of fever, sore throat, nausea, diarrhea, congestion, and headache. Although they refused COVID-19 vaccination, they presented for the casirivimab and imdevimab monoclonal antibody cock...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ryan, Mangal, Rohan, Stead, Thor S, Barbera, Andrew R, Ganti, Latha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Emergency Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449254/
https://www.ncbi.nlm.nih.gov/pubmed/36106219
http://dx.doi.org/10.7759/cureus.27766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449254/
https://www.ncbi.nlm.nih.gov/pubmed/36106219
http://dx.doi.org/10.7759/cureus.27766

Ejemplares similares